UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Immunogenicity of biologic therapies for migraine: a review of current evidence

Journal of headache and pain, 2021-01, Vol.22 (1), p.3-8, Article 3

2021

Link zum Volltext

Verfügbarkeit prüfen

Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States

Journal of headache and pain, 2021-12, Vol.22 (1), p.156-156, Article 156

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies

Journal of headache and pain, 2021-11, Vol.22 (1), p.141-141, Article 141

2021

Link zum Volltext

Verfügbarkeit prüfen

A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States

Journal of headache and pain, 2022-05, Vol.23 (1), p.54-54, Article 54

2022

Link zum Volltext

Verfügbarkeit prüfen

Commentary: Constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related peptide's motor-stimulating and prosecretory function in the intestine

Frontiers in physiology, 2022-11, Vol.13, p.1067274-1067274

2022

Link zum Volltext

Verfügbarkeit prüfen

Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies

Journal of headache and pain, 2022-05, Vol.23 (1), p.57-57, Article 57

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-world Impact of Fremanezumab on Migraine-Related Health Care Resource Utilization in Patients with Comorbidities, Acute Medication Overuse, and/or Unsatisfactory Prior Migraine Preventive Response

Pain and therapy, 2024-06, Vol.13 (3), p.511-532

2024

Link zum Volltext

Verfügbarkeit prüfen

Real-world effectiveness of add-on fremanezumab in patients receiving onabotulinumtoxinA for the prevention of chronic migraine in a US tertiary headache center: A retrospective chart review study

Cephalalgia reports, 2024-01, Vol.7

2024

Link zum Volltext

Verfügbarkeit prüfen

Reducing the Burden of Migraine: Safety and Efficacy of CGRP Pathway-Targeted Preventive Treatments

Journal of clinical medicine, 2022-07, Vol.11 (15), p.4359

2022

Link zum Volltext

Verfügbarkeit prüfen

A Review of Complementary and Alternative Medicine Use Among U.S. Adults with Headache or Migraine: Results from the 2012 National Health Interview Survey

Headache, 2017-09, Vol.57 (8), p.1284-1285

Krasenbaum, Lynda J.

2017

Link zum Volltext

Verfügbarkeit prüfen

A Review of HIV and Headache: A Cross‐Sectional Study

Headache, 2017-11, Vol.57 (10), p.1631-1632

Krasenbaum, Lynda J.

2017

Link zum Volltext

Verfügbarkeit prüfen

A Review of Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States

Headache, 2017-10, Vol.57 (9), p.1451-1452

Krasenbaum, Lynda J.

2017

Link zum Volltext

Verfügbarkeit prüfen

A Review of Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results From the American Migraine Prevalence and Prevention Study

Headache, 2017-07, Vol.57 (7), p.1156-1157

Krasenbaum, Lynda J.

2017

Link zum Volltext

Verfügbarkeit prüfen

A Review of CGRP and Its Receptors

Headache, 2017-04, Vol.57 (4), p.670-671

Krasenbaum, Lynda J

2017

Link zum Volltext

Verfügbarkeit prüfen

A Review of Vomiting and Migraine‐Related Clinical Parameters in Pediatric Migraine

Headache, 2017-06, Vol.57 (6), p.979-980

Krasenbaum, Lynda J.

2017

Link zum Volltext

Verfügbarkeit prüfen

A Review of Radiofrequency for Arteriovenous Malformations and the Impact on Headache

Headache, 2017-05, Vol.57 (5), p.812-813

Krasenbaum, Lynda J.

2017

Link zum Volltext

Verfügbarkeit prüfen

A Review of “Untangling the Association Between Migraine, Pain, and Anxiety: Examining Migraine and Generalized Anxiety Disorders in a Canadian Population Based Study”

Headache, 2017-03, Vol.57 (3), p.500-501

Krasenbaum, Lynda J.

2017

Link zum Volltext

Verfügbarkeit prüfen

A Review of “Hormonal Contraceptives and Migraine With Aura – Is There Still a Risk?”

Headache, 2017-02, Vol.57 (2), p.313-313

Krasenbaum, Lynda J

2017

Link zum Volltext

Verfügbarkeit prüfen

A Review of “Peripheral Nerve Blocks for the Treatment of Headache in Older Adults: A Retrospective Study”

Headache, 2017-01, Vol.57 (1), p.128-128

Krasenbaum, Lynda J

2017

Link zum Volltext

Verfügbarkeit prüfen

Burden of migraine with acute medication overuse or psychiatric comorbidities and treatment with CGRP pathway-targeted monoclonal antibodies: A review

Medicine (Baltimore), 2023-06, Vol.102 (23), p.e33874-e33874

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical characteristics and patient‐reported outcomes of chronic and episodic migraine patients at a US tertiary headache center: A retrospective observational study

Headache, 2023-07, Vol.63 (7), p.908-916

2023

Link zum Volltext

Verfügbarkeit prüfen

Comment on: Gao B, Lu Q, Wan R, Wang Z, Yang Y, Chen Z, Wang Z. “Monthly versus quarterly fremanezumab for the prevention of migraine: a systemic review and meta-analysis from randomized controlled trials”. Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):819–828. Epublished November 2020

Naunyn-Schmiedeberg's archives of pharmacology, 2021-11, Vol.394 (11), p.2343-2346

2021

Link zum Volltext

Verfügbarkeit prüfen

A Review of Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the U nited S tates

Headache, 2017-10, Vol.57 (9), p.1451-1452

Krasenbaum, Lynda J.

2017

Link zum Volltext

Verfügbarkeit prüfen

A Review of Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results From the A merican Migraine Prevalence and Prevention Study

Headache, 2017-07, Vol.57 (7), p.1156-1157

Krasenbaum, Lynda J.

2017

Link zum Volltext

Verfügbarkeit prüfen

Reversion from medication overuse with fremanezumab treatment in patients with inadequate response to multiple migraine preventive medication classes

Journal of the neurological sciences, 2021-10, Vol.429, p.119295, Article 119295

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Headache
(13)
Journal Of Headache And Pain
(5)
Cephalalgia Reports
(1)
Frontiers In Physiology
(1)
Journal Of Clinical Medicine
(1)
Journal Of The Neurological Sciences
(1)
Medicine
(1)
Naunyn-Schmiedeberg's Archives Of Pharmacology
(1)
Pain And Therapy
(1)

4 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunogenicity of biologic therapies for migraine: a review of current evidence

Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States

Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies

A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States

Commentary: Constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related peptide's motor-stimulating and prosecretory function in the intestine

Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies

Real-world Impact of Fremanezumab on Migraine-Related Health Care Resource Utilization in Patients with Comorbidities, Acute Medication Overuse, and/or Unsatisfactory Prior Migraine Preventive Response

Real-world effectiveness of add-on fremanezumab in patients receiving onabotulinumtoxinA for the prevention of chronic migraine in a US tertiary headache center: A retrospective chart review study

Reducing the Burden of Migraine: Safety and Efficacy of CGRP Pathway-Targeted Preventive Treatments

A Review of Complementary and Alternative Medicine Use Among U.S. Adults with Headache or Migraine: Results from the 2012 National Health Interview Survey

A Review of HIV and Headache: A Cross‐Sectional Study

A Review of Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States

A Review of Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results From the American Migraine Prevalence and Prevention Study

A Review of CGRP and Its Receptors

A Review of Vomiting and Migraine‐Related Clinical Parameters in Pediatric Migraine

A Review of Radiofrequency for Arteriovenous Malformations and the Impact on Headache

A Review of “Untangling the Association Between Migraine, Pain, and Anxiety: Examining Migraine and Generalized Anxiety Disorders in a Canadian Population Based Study”

A Review of “Hormonal Contraceptives and Migraine With Aura – Is There Still a Risk?”

A Review of “Peripheral Nerve Blocks for the Treatment of Headache in Older Adults: A Retrospective Study”

Burden of migraine with acute medication overuse or psychiatric comorbidities and treatment with CGRP pathway-targeted monoclonal antibodies: A review

Clinical characteristics and patient‐reported outcomes of chronic and episodic migraine patients at a US tertiary headache center: A retrospective observational study

Comment on: Gao B, Lu Q, Wan R, Wang Z, Yang Y, Chen Z, Wang Z. “Monthly versus quarterly fremanezumab for the prevention of migraine: a systemic review and meta-analysis from randomized controlled trials”. Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):819–828. Epublished November 2020

A Review of Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the U nited S tates

A Review of Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results From the A merican Migraine Prevalence and Prevention Study

Reversion from medication overuse with fremanezumab treatment in patients with inadequate response to multiple migraine preventive medication classes

Suchergebnisse filtern